Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: Cancer Res. 2009 Apr 7;69(8):10.1158/0008-5472.CAN-08-4884. doi: 10.1158/0008-5472.CAN-08-4884

Figure 2. PI-103 activates caspase-9 and -3 in CEM-R and MOLT-4 cells, while rapamycin activates caspase-9 and -3 in MOLT-4 cells only.

Figure 2

CEM-R and MOLT-4 cells were treated with PI-103 (0.75 µM) or rapamycin (0.1 µM) for the indicated times, collected, and then lysed. Fifty micrograms of each lysate were electrophoresed on SDS-PAGE gels followed by transfer to nitrocellulose membrane.